111 related articles for article (PubMed ID: 37982229)
1. Monomeric myeloperoxidase is a specific biomarker for early-stage ovarian cancer.
Saed GM; Nawaz A; Alvero AA; Harper AK; Morris RT
Biomarkers; 2023 Dec; 28(7):663-671. PubMed ID: 37982229
[No Abstract] [Full Text] [Related]
2. Neutrophil activation in response to monomeric myeloperoxidase.
Gorudko IV; Grigorieva DV; Sokolov AV; Shamova EV; Kostevich VA; Kudryavtsev IV; Syromiatnikova ED; Vasilyev VB; Cherenkevich SN; Panasenko OM
Biochem Cell Biol; 2018 Oct; 96(5):592-601. PubMed ID: 29585927
[TBL] [Abstract][Full Text] [Related]
3. The effect of myeloperoxidase isoforms on biophysical properties of red blood cells.
Shamova EV; Gorudko IV; Grigorieva DV; Sokolov AV; Kokhan AU; Melnikova GB; Yafremau NA; Gusev SA; Sveshnikova AN; Vasilyev VB; Cherenkevich SN; Panasenko OM
Mol Cell Biochem; 2020 Jan; 464(1-2):119-130. PubMed ID: 31754972
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase and free iron levels: potential biomarkers for early detection and prognosis of ovarian cancer.
Fletcher NM; Jiang Z; Ali-Fehmi R; Levin NK; Belotte J; Tainsky MA; Diamond MP; Abu-Soud HM; Saed GM
Cancer Biomark; 2011-2012; 10(6):267-75. PubMed ID: 22820082
[TBL] [Abstract][Full Text] [Related]
5. Binding of Intracellular Myeloperoxidase to αV/β1 Integrin Serves as a Mechanism of Survival in Epithelial Ovarian Cancer.
Harper AK; Kirsch-Mangu TK; Lutfi H; Morris RT; Saed GM
Reprod Sci; 2023 Jan; 30(1):291-300. PubMed ID: 35799017
[TBL] [Abstract][Full Text] [Related]
6. [Enzymatic and bactericidal activity of monomeric and dimeric forms of myeloperoxidase].
Vakhrusheva TV; Sokolov AV; Kostevich VA; Vasilyev VB; Panasenko OM
Biomed Khim; 2018 Mar; 64(2):175-182. PubMed ID: 29723147
[TBL] [Abstract][Full Text] [Related]
7. Structure-biological activity relationships of myeloperoxidase to effect on platelet activation.
Gorudko IV; Grigorieva DV; Shamova EV; Gorbunov NP; Kokhan AU; Kostevich VA; Vasilyev VB; Panasenko OM; Khinevich NV; Bandarenka HV; Burko AA; Sokolov AV
Arch Biochem Biophys; 2022 Oct; 728():109353. PubMed ID: 35853481
[TBL] [Abstract][Full Text] [Related]
8. The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.
Tamir A; Gangadharan A; Balwani S; Tanaka T; Patel U; Hassan A; Benke S; Agas A; D'Agostino J; Shin D; Yoon S; Goy A; Pecora A; Suh KS
J Ovarian Res; 2016 Mar; 9():20. PubMed ID: 27036110
[TBL] [Abstract][Full Text] [Related]
9. Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients.
Leung F; Dimitromanolakis A; Kobayashi H; Diamandis EP; Kulasingam V
Clin Biochem; 2013 Oct; 46(15):1462-8. PubMed ID: 23528302
[TBL] [Abstract][Full Text] [Related]
10. MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity.
Droeser RA; Mechera R; Däster S; Weixler B; Kraljević M; Delko T; Güth U; Stadlmann S; Terracciano L; Singer G
BMC Cancer; 2016 Aug; 16():639. PubMed ID: 27531373
[TBL] [Abstract][Full Text] [Related]
11. Association of myeloperoxidase with ovarian cancer.
Castillo-Tong DC; Pils D; Heinze G; Braicu I; Sehouli J; Reinthaller A; Schuster E; Wolf A; Watrowski R; Maki RA; Zeillinger R; Reynolds WF
Tumour Biol; 2014 Jan; 35(1):141-8. PubMed ID: 23893381
[TBL] [Abstract][Full Text] [Related]
12. Association of monocyte myeloperoxidase with incident cardiovascular disease: The Atherosclerosis Risk in Communities Study.
Oyenuga AO; Couper D; Matsushita K; Boerwinkle E; Folsom AR
PLoS One; 2018; 13(10):e0205310. PubMed ID: 30300402
[TBL] [Abstract][Full Text] [Related]
13. Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypes.
Ren AH; Filippou PS; Soosaipillai A; Dimitrakopoulos L; Korbakis D; Leung F; Kulasingam V; Bernardini MQ; Diamandis EP
Clin Chem Lab Med; 2023 Feb; 61(3):464-472. PubMed ID: 36380677
[TBL] [Abstract][Full Text] [Related]
14. Development of a multimarker assay for early detection of ovarian cancer.
Yurkovetsky Z; Skates S; Lomakin A; Nolen B; Pulsipher T; Modugno F; Marks J; Godwin A; Gorelik E; Jacobs I; Menon U; Lu K; Badgwell D; Bast RC; Lokshin AE
J Clin Oncol; 2010 May; 28(13):2159-66. PubMed ID: 20368574
[TBL] [Abstract][Full Text] [Related]
15. Myeloperoxidase serves as a redox switch that regulates apoptosis in epithelial ovarian cancer.
Saed GM; Ali-Fehmi R; Jiang ZL; Fletcher NM; Diamond MP; Abu-Soud HM; Munkarah AR
Gynecol Oncol; 2010 Feb; 116(2):276-81. PubMed ID: 19962178
[TBL] [Abstract][Full Text] [Related]
16. A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma.
Han C; Bellone S; Siegel ER; Altwerger G; Menderes G; Bonazzoli E; Egawa-Takata T; Pettinella F; Bianchi A; Riccio F; Zammataro L; Yadav G; Marto JA; Penet MF; Levine DA; Drapkin R; Patel A; Litkouhi B; Ratner E; Silasi DA; Huang GS; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2018 Jun; 149(3):585-591. PubMed ID: 29572027
[TBL] [Abstract][Full Text] [Related]
17. Human epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinoma.
Chang X; Ye X; Dong L; Cheng H; Cheng Y; Zhu L; Liao Q; Zhao Y; Tian L; Fu T; Chen J; Cui H
Int J Gynecol Cancer; 2011 Jul; 21(5):852-8. PubMed ID: 21633297
[TBL] [Abstract][Full Text] [Related]
18. LyGDI is a promising biomarker for ovarian cancer.
Zhen H; Yang S; Wu H; Wang S; Lv J; Ma L; Zhang X
Int J Gynecol Cancer; 2010 Apr; 20(3):316-22. PubMed ID: 20375790
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types.
Kobayashi M; Sawada K; Nakamura K; Yoshimura A; Miyamoto M; Shimizu A; Ishida K; Nakatsuka E; Kodama M; Hashimoto K; Mabuchi S; Kimura T
J Ovarian Res; 2018 Sep; 11(1):81. PubMed ID: 30219071
[TBL] [Abstract][Full Text] [Related]
20. Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.
Shah CA; Lowe KA; Paley P; Wallace E; Anderson GL; McIntosh MW; Andersen MR; Scholler N; Bergan LA; Thorpe JD; Urban N; Drescher CW
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1365-72. PubMed ID: 19423517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
